CGN Advisors’s Synopsys SNPS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.08M Sell
4,660
-141
-3% -$66.3K 0.15% 126
2026
Q1
$1.9M Sell
4,801
-40
-0.8% -$18.1K 0.15% 130
2025
Q4
$2.27M Buy
4,841
+487
+11% +$216K 0.18% 116
2025
Q3
$2.15M Sell
4,354
-24
-0.5% -$13.6K 0.18% 118
2025
Q2
$2.24M Buy
4,378
+192
+5% +$89.5K 0.2% 106
2025
Q1
$1.8M Buy
4,186
+1,419
+51% +$689K 0.18% 128
2024
Q4
$1.34M Buy
2,767
+479
+21% +$250K 0.13% 144
2024
Q3
$1.16M Buy
2,288
+546
+31% +$293K 0.12% 154
2024
Q2
$1.04M Buy
+1,742
New +$985K 0.12% 155

Other funds holding SNPS

CGN Advisors's SNPS Position: Q2 2026 in Review

CGN Advisors reduced its Synopsys (SNPS) stake by 2.9% in Q2 2026, selling an estimated $66.3K and leaving 4,660 shares worth $2.08M. The position accounts for 0.15% of the portfolio, ranked #126.

CGN Advisors first reported a position in SNPS in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.27M in Q4 2025. 1,444 funds tracked by Wall St. Rank hold SNPS as of Q2 2026.

  • CGN Advisors held 4,660 shares of Synopsys worth $2.08M as of Q2 2026.
  • CGN Advisors sold 141 Synopsys shares in Q2 2026, an estimated $66.3K.
  • Synopsys made up 0.15% of CGN Advisors's portfolio in Q2 2026, its #126 holding.
  • CGN Advisors first reported a position in Synopsys in Q2 2024 and has held it in 9 quarters since.
  • CGN Advisors's Synopsys position peaked at $2.27M in Q4 2025.
  • 1,444 funds tracked by Wall St. Rank held Synopsys as of Q2 2026.

Based on CGN Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.